Home >> Industry News >> Hologic granted EUA for second molecular test for COVID-19

Hologic granted EUA for second molecular test for COVID-19

image_pdfCreate PDF

May 15, 2020—Hologic announced it has received emergency use authorization from the FDA for its Aptima SARS-CoV-2 assay to detect the novel coronavirus.

The test runs on Hologic’s fully automated Panther system, more than 1,000 of which are installed in clinical laboratories throughout the United States. The Panther system can provide initial results in about three hours and process more than 1,000 coronavirus tests in 24 hours. The company has begun distributing its new test and expects to produce an average of one million tests per week.

CAP TODAY
X